SlideShare una empresa de Scribd logo
1 de 32
New Drug Application(NDA)  Vs   Abbreviated new drug application  (ANDA) ,[object Object],[object Object],[object Object],[object Object],Name: Sneya Priya Year : M.Pharm( Pharmaceutics) College:  Manipal college of Pharmaceutical Scieces(MCOPS), Manipal Email id: snehpriya123@gmail.com
Contents  ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
New Drug Application ,[object Object],[object Object],[object Object],[object Object],[object Object]
NDA Classifications   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
New Drug Development and Review Process Steps from Test Tube to New Drug Application Review
Phases of clinical testing Phase Number of patients Length Purpose Percent  successfully completing Phase1 20-100 Several months Mainly safety 67 Phase2 Up to several hundred Several months to two years Some short-term safety but mainly effectiveness 45 Phase3 Several hundred to several thousand 1-4 years Safety, effectiveness, dosage 5-10
NDA Review Process
NDA CONTENTS ,[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object]
[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
The NDA in CTD Format Module 1 is not part of the CTD because it is not harmonized CTD NDA: 314.50 Module 1 ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Module 2 c)Summaries d)5.7  Abuse potential Module 3 d)1 CMC Module 4 d)2 Nonclinical pharm/tox Module  d)3 Human PK d)4 Microbiology d)5 Clinical data  d)6 Statistical section f) CRF and CRT
ANDA   ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Goal of ANDA ,[object Object],[object Object],[object Object]
ANDA Review process
NDA vs. ANDA Review Process ,[object Object],[object Object]
What is Bioequivalence?  ,[object Object],[object Object],[object Object]
Patent Certification condition for ANDA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Paragraph IV certification ,[object Object],[object Object],[object Object],[object Object]
Patent Challenge Successful – Award of 180-Day Exclusivity Period  ,[object Object],[object Object],[object Object],[object Object],[object Object]
Orphan Drug Exclusivity (ODE)  ,[object Object],[object Object],[object Object],[object Object]
ANDA approval status
CONCLUSION NDA ANDA Applicable for new drug Applicable for generic drug Take longer time ( 12-15 years) Compare to NAD less time taken(1-2 years) More expenditure of money  Comparatively less Cost of drugs are more Cost of drugs are less Nonclinical studies and clinical investigations are essential  Nonclinical studies and clinical investigations are nonessential except bioavailability and bioequivalence
REFERENCES  ,[object Object],[object Object],[object Object],[object Object]
[object Object]

Más contenido relacionado

La actualidad más candente

Regulatory Requirements for Drug Product Approval
Regulatory Requirements for Drug Product ApprovalRegulatory Requirements for Drug Product Approval
Regulatory Requirements for Drug Product ApprovalAtul Adhikari
 
INVESTIGATOR’S BROCHURE (IB)
 INVESTIGATOR’S BROCHURE (IB) INVESTIGATOR’S BROCHURE (IB)
INVESTIGATOR’S BROCHURE (IB)SachinFartade
 
Global Subbmission of IND, NDA, ANDA
Global Subbmission of IND, NDA, ANDA Global Subbmission of IND, NDA, ANDA
Global Subbmission of IND, NDA, ANDA Maruthi.N
 
NDA and ANDA regulatory approval process
NDA and ANDA regulatory approval processNDA and ANDA regulatory approval process
NDA and ANDA regulatory approval processJagrutiKale1
 
DMF Drug Master File
DMF   Drug Master FileDMF   Drug Master File
DMF Drug Master FileRushi Mendhe
 
Pharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxPharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxRoshan Yadav
 
Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical DocumentDr Sukanta sen
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)Suvarta Maru
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]Sagar Savale
 
Generic drugs product development
Generic drugs product developmentGeneric drugs product development
Generic drugs product developmentSachin G
 
New drug application
New drug applicationNew drug application
New drug applicationVKEkbote
 
Certificate of pharmaceutical product
Certificate of pharmaceutical productCertificate of pharmaceutical product
Certificate of pharmaceutical productAtul Bhombe
 
Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRODhanshreeBhattad
 
Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)bdvfgbdhg
 

La actualidad más candente (20)

Ctd and e ctd
Ctd and e ctdCtd and e ctd
Ctd and e ctd
 
Regulatory Requirements for Drug Product Approval
Regulatory Requirements for Drug Product ApprovalRegulatory Requirements for Drug Product Approval
Regulatory Requirements for Drug Product Approval
 
INVESTIGATOR’S BROCHURE (IB)
 INVESTIGATOR’S BROCHURE (IB) INVESTIGATOR’S BROCHURE (IB)
INVESTIGATOR’S BROCHURE (IB)
 
Global Subbmission of IND, NDA, ANDA
Global Subbmission of IND, NDA, ANDA Global Subbmission of IND, NDA, ANDA
Global Subbmission of IND, NDA, ANDA
 
NDA and ANDA regulatory approval process
NDA and ANDA regulatory approval processNDA and ANDA regulatory approval process
NDA and ANDA regulatory approval process
 
DMF Drug Master File
DMF   Drug Master FileDMF   Drug Master File
DMF Drug Master File
 
ANDA
ANDAANDA
ANDA
 
Nda
NdaNda
Nda
 
Pharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptxPharmacovigilance safety Mon. in clinical trials.pptx
Pharmacovigilance safety Mon. in clinical trials.pptx
 
Common Technical Document
Common Technical DocumentCommon Technical Document
Common Technical Document
 
NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)NEW DRUG APPLICATION ( NDA)
NEW DRUG APPLICATION ( NDA)
 
New Drug Application [NDA]
New Drug Application [NDA]New Drug Application [NDA]
New Drug Application [NDA]
 
Supac
SupacSupac
Supac
 
Generic drugs product development
Generic drugs product developmentGeneric drugs product development
Generic drugs product development
 
Hatch Waxman Act
Hatch Waxman ActHatch Waxman Act
Hatch Waxman Act
 
New drug application
New drug applicationNew drug application
New drug application
 
Certificate of pharmaceutical product
Certificate of pharmaceutical productCertificate of pharmaceutical product
Certificate of pharmaceutical product
 
Outsourcing BA and BE to CRO
Outsourcing BA and BE to CROOutsourcing BA and BE to CRO
Outsourcing BA and BE to CRO
 
Scale up and post approval changes(supac)
Scale up and post approval changes(supac)Scale up and post approval changes(supac)
Scale up and post approval changes(supac)
 
hatch-waxman act@amendments
hatch-waxman act@amendmentshatch-waxman act@amendments
hatch-waxman act@amendments
 

Destacado

ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crastoABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crastoAnthony Melvin Crasto Ph.D
 
Investigational new drug application new
Investigational new drug application newInvestigational new drug application new
Investigational new drug application newAakrati Gupta
 
Good manufacturing practices (schedule m)
Good manufacturing practices (schedule m)Good manufacturing practices (schedule m)
Good manufacturing practices (schedule m)Bindu Kshtriya
 
US and EU Submission – Comparative
US and EU Submission – ComparativeUS and EU Submission – Comparative
US and EU Submission – ComparativeGirish Swami
 
Abbreviated New Drug Application [ANDA]
Abbreviated New Drug Application [ANDA]Abbreviated New Drug Application [ANDA]
Abbreviated New Drug Application [ANDA]Sagar Savale
 
Abriviated new drug application
Abriviated new drug applicationAbriviated new drug application
Abriviated new drug applicationGaurav Kr
 
The Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) ProcessThe Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) ProcessCarrie O'Connor
 
Drugs approved in 2010
Drugs approved in 2010Drugs approved in 2010
Drugs approved in 2010Naveen Kumar
 
Steps involved in dosage development of new drug
Steps involved in dosage development of new drugSteps involved in dosage development of new drug
Steps involved in dosage development of new drugmadhuri muramshetty
 
Inprocess as per usp ip bp tablets
Inprocess as per usp ip bp tabletsInprocess as per usp ip bp tablets
Inprocess as per usp ip bp tabletsDeepak Jain
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and ndaswati2084
 
Pharmaceutical waste management
Pharmaceutical waste managementPharmaceutical waste management
Pharmaceutical waste managementImad Nmeir
 
PHARMACEUTICAL WASTE MANAGEMENT IN INDIA
PHARMACEUTICAL WASTE MANAGEMENT IN INDIAPHARMACEUTICAL WASTE MANAGEMENT IN INDIA
PHARMACEUTICAL WASTE MANAGEMENT IN INDIAAakashdeep Raval
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and developmentKarun Kumar
 

Destacado (20)

ANDA filing
ANDA filingANDA filing
ANDA filing
 
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crastoABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
ABBREVIATED NEW DRUG APPLICATION (ANDA) by Anthony crasto
 
Investigational new drug application new
Investigational new drug application newInvestigational new drug application new
Investigational new drug application new
 
Good manufacturing practices (schedule m)
Good manufacturing practices (schedule m)Good manufacturing practices (schedule m)
Good manufacturing practices (schedule m)
 
US and EU Submission – Comparative
US and EU Submission – ComparativeUS and EU Submission – Comparative
US and EU Submission – Comparative
 
Abbreviated New Drug Application [ANDA]
Abbreviated New Drug Application [ANDA]Abbreviated New Drug Application [ANDA]
Abbreviated New Drug Application [ANDA]
 
Abriviated new drug application
Abriviated new drug applicationAbriviated new drug application
Abriviated new drug application
 
The Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) ProcessThe Investigational New Drug (IND) and New Drug Application (NDA) Process
The Investigational New Drug (IND) and New Drug Application (NDA) Process
 
Patents & market exclusivity
Patents & market exclusivityPatents & market exclusivity
Patents & market exclusivity
 
Drugs approved in 2010
Drugs approved in 2010Drugs approved in 2010
Drugs approved in 2010
 
Steps involved in dosage development of new drug
Steps involved in dosage development of new drugSteps involved in dosage development of new drug
Steps involved in dosage development of new drug
 
Nda ipr
Nda  iprNda  ipr
Nda ipr
 
Inprocess as per usp ip bp tablets
Inprocess as per usp ip bp tabletsInprocess as per usp ip bp tablets
Inprocess as per usp ip bp tablets
 
Drug Discovery New Drug Development Process
Drug Discovery New Drug Development ProcessDrug Discovery New Drug Development Process
Drug Discovery New Drug Development Process
 
Ind (investigational new drug application) and nda
Ind (investigational new drug application) and ndaInd (investigational new drug application) and nda
Ind (investigational new drug application) and nda
 
New Drug Development Process
New Drug Development ProcessNew Drug Development Process
New Drug Development Process
 
Pharmaceutical waste management
Pharmaceutical waste managementPharmaceutical waste management
Pharmaceutical waste management
 
PHARMACEUTICAL WASTE MANAGEMENT IN INDIA
PHARMACEUTICAL WASTE MANAGEMENT IN INDIAPHARMACEUTICAL WASTE MANAGEMENT IN INDIA
PHARMACEUTICAL WASTE MANAGEMENT IN INDIA
 
Anda ppt
Anda pptAnda ppt
Anda ppt
 
Drug discovery and development
Drug discovery and developmentDrug discovery and development
Drug discovery and development
 

Similar a NDA vs ANDA Comparison

New drug application
New drug applicationNew drug application
New drug applicationnishuyadav17
 
Seminar on NDA approval process.pptx
Seminar on NDA approval process.pptxSeminar on NDA approval process.pptx
Seminar on NDA approval process.pptxPawanDhamala1
 
akshay regulatory seminar 1 productregistrationanddrugapprovalprocessinus.ppt
akshay regulatory seminar 1    productregistrationanddrugapprovalprocessinus.pptakshay regulatory seminar 1    productregistrationanddrugapprovalprocessinus.ppt
akshay regulatory seminar 1 productregistrationanddrugapprovalprocessinus.pptGaneshSureshKumbhar
 
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...Audumbar Mali
 
Global Submission of IND& NDA pptx
Global Submission of IND& NDA pptxGlobal Submission of IND& NDA pptx
Global Submission of IND& NDA pptxchitrangpatil700
 
Product registration and drug approval process in us
Product registration and drug approval process in usProduct registration and drug approval process in us
Product registration and drug approval process in uskeerthi09
 
INDA- Investigation New Drug Application
INDA- Investigation New Drug ApplicationINDA- Investigation New Drug Application
INDA- Investigation New Drug ApplicationDr. Jigar Vyas
 
Regulatory Affairs - IND,NDA,ANDA
Regulatory Affairs - IND,NDA,ANDARegulatory Affairs - IND,NDA,ANDA
Regulatory Affairs - IND,NDA,ANDALingrajGc
 
GLOBAL SUBMISSION OF IND, NDA, ANDA.pdf
GLOBAL SUBMISSION OF IND, NDA, ANDA.pdfGLOBAL SUBMISSION OF IND, NDA, ANDA.pdf
GLOBAL SUBMISSION OF IND, NDA, ANDA.pdfLokeshThakre6
 
New Drug Application (NDA) Filing
New Drug Application (NDA) Filing New Drug Application (NDA) Filing
New Drug Application (NDA) Filing SimranDhiman12
 
Global Submission ANDA.pptx
Global Submission ANDA.pptxGlobal Submission ANDA.pptx
Global Submission ANDA.pptxRAHUL PAL
 
Global Submission ANDA-.pdf
Global Submission ANDA-.pdfGlobal Submission ANDA-.pdf
Global Submission ANDA-.pdfPrachi Pandey
 
Global Submission ANDA.pptx
Global Submission ANDA.pptxGlobal Submission ANDA.pptx
Global Submission ANDA.pptxPrachi Pandey
 
NDA- New Drug Application process.pptx
NDA- New Drug Application process.pptxNDA- New Drug Application process.pptx
NDA- New Drug Application process.pptxDhruv989892
 

Similar a NDA vs ANDA Comparison (20)

NDS V'S ANDA
NDS V'S ANDANDS V'S ANDA
NDS V'S ANDA
 
NDA Vs ANDA
NDA Vs ANDANDA Vs ANDA
NDA Vs ANDA
 
New drug application
New drug applicationNew drug application
New drug application
 
Seminar on NDA approval process.pptx
Seminar on NDA approval process.pptxSeminar on NDA approval process.pptx
Seminar on NDA approval process.pptx
 
akshay regulatory seminar 1 productregistrationanddrugapprovalprocessinus.ppt
akshay regulatory seminar 1    productregistrationanddrugapprovalprocessinus.pptakshay regulatory seminar 1    productregistrationanddrugapprovalprocessinus.ppt
akshay regulatory seminar 1 productregistrationanddrugapprovalprocessinus.ppt
 
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
BP804 ET: PHARMACEUTICAL REGULATORY SCIENCE (Theory)2. unit ii, chapter-1 reg...
 
NDA ANDA IND by Anthony Crasto
NDA ANDA IND by Anthony CrastoNDA ANDA IND by Anthony Crasto
NDA ANDA IND by Anthony Crasto
 
Global Submission of IND& NDA pptx
Global Submission of IND& NDA pptxGlobal Submission of IND& NDA pptx
Global Submission of IND& NDA pptx
 
Nda
NdaNda
Nda
 
Product registration and drug approval process in us
Product registration and drug approval process in usProduct registration and drug approval process in us
Product registration and drug approval process in us
 
INDA/NDA/ANDA
INDA/NDA/ANDAINDA/NDA/ANDA
INDA/NDA/ANDA
 
INDA- Investigation New Drug Application
INDA- Investigation New Drug ApplicationINDA- Investigation New Drug Application
INDA- Investigation New Drug Application
 
Regulatory Affairs - IND,NDA,ANDA
Regulatory Affairs - IND,NDA,ANDARegulatory Affairs - IND,NDA,ANDA
Regulatory Affairs - IND,NDA,ANDA
 
GLOBAL SUBMISSION OF IND, NDA, ANDA.pdf
GLOBAL SUBMISSION OF IND, NDA, ANDA.pdfGLOBAL SUBMISSION OF IND, NDA, ANDA.pdf
GLOBAL SUBMISSION OF IND, NDA, ANDA.pdf
 
New Drug Application (NDA) Filing
New Drug Application (NDA) Filing New Drug Application (NDA) Filing
New Drug Application (NDA) Filing
 
regulatory sk.pptx
regulatory sk.pptxregulatory sk.pptx
regulatory sk.pptx
 
Global Submission ANDA.pptx
Global Submission ANDA.pptxGlobal Submission ANDA.pptx
Global Submission ANDA.pptx
 
Global Submission ANDA-.pdf
Global Submission ANDA-.pdfGlobal Submission ANDA-.pdf
Global Submission ANDA-.pdf
 
Global Submission ANDA.pptx
Global Submission ANDA.pptxGlobal Submission ANDA.pptx
Global Submission ANDA.pptx
 
NDA- New Drug Application process.pptx
NDA- New Drug Application process.pptxNDA- New Drug Application process.pptx
NDA- New Drug Application process.pptx
 

NDA vs ANDA Comparison

  • 1.
  • 2.
  • 3.
  • 4.
  • 5. New Drug Development and Review Process Steps from Test Tube to New Drug Application Review
  • 6. Phases of clinical testing Phase Number of patients Length Purpose Percent successfully completing Phase1 20-100 Several months Mainly safety 67 Phase2 Up to several hundred Several months to two years Some short-term safety but mainly effectiveness 45 Phase3 Several hundred to several thousand 1-4 years Safety, effectiveness, dosage 5-10
  • 7.
  • 8.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 30. CONCLUSION NDA ANDA Applicable for new drug Applicable for generic drug Take longer time ( 12-15 years) Compare to NAD less time taken(1-2 years) More expenditure of money Comparatively less Cost of drugs are more Cost of drugs are less Nonclinical studies and clinical investigations are essential Nonclinical studies and clinical investigations are nonessential except bioavailability and bioequivalence
  • 31.
  • 32.